DK1173439T3 - Halogenalkoxy-imidazonaphthyridiner - Google Patents

Halogenalkoxy-imidazonaphthyridiner

Info

Publication number
DK1173439T3
DK1173439T3 DK00918882T DK00918882T DK1173439T3 DK 1173439 T3 DK1173439 T3 DK 1173439T3 DK 00918882 T DK00918882 T DK 00918882T DK 00918882 T DK00918882 T DK 00918882T DK 1173439 T3 DK1173439 T3 DK 1173439T3
Authority
DK
Denmark
Prior art keywords
imidazonaphthyridiner
haloalkoxy
compounds
useful
preventing
Prior art date
Application number
DK00918882T
Other languages
English (en)
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1173439T3 publication Critical patent/DK1173439T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK00918882T 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner DK1173439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (1)

Publication Number Publication Date
DK1173439T3 true DK1173439T3 (da) 2003-09-08

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918882T DK1173439T3 (da) 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner

Country Status (12)

Country Link
US (1) US6503923B1 (da)
EP (1) EP1173439B1 (da)
JP (1) JP2002542248A (da)
AT (1) ATE240956T1 (da)
AU (1) AU3966600A (da)
CA (1) CA2370231A1 (da)
DE (1) DE60002855T2 (da)
DK (1) DK1173439T3 (da)
ES (1) ES2199810T3 (da)
PT (1) PT1173439E (da)
SI (1) SI1173439T1 (da)
WO (1) WO2000063211A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0114873A (pt) * 2000-10-25 2003-07-01 Altana Pharma Ag Imidazopiridinas polissubstituìdas
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
CA2452802A1 (en) 2001-08-02 2003-02-20 Altana Pharma Ag Tricyclic epoxides
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
MXPA04001048A (es) * 2001-08-03 2004-05-20 Altana Pharma Ag Imidazopiridinas sustituidas con alquilo, para el tratamiento de trastornos gastrointestinales.
EP1476445A1 (en) 2002-02-15 2004-11-17 ALTANA Pharma AG Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003288071A1 (en) 2002-11-19 2004-06-15 Altana Pharma Ag 8-substituted imidazopyridines
RS20050603A (en) * 2003-02-17 2007-09-21 Altana Pharma Ag., New combinations and new application of pharmaceutically active compounds
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
AU2005291284A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO1998042707A1 (en) 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
EE04677B1 (et) * 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Also Published As

Publication number Publication date
ES2199810T3 (es) 2004-03-01
US6503923B1 (en) 2003-01-07
AU3966600A (en) 2000-11-02
DE60002855D1 (de) 2003-06-26
WO2000063211A1 (en) 2000-10-26
EP1173439A1 (en) 2002-01-23
SI1173439T1 (en) 2003-10-31
JP2002542248A (ja) 2002-12-10
CA2370231A1 (en) 2000-10-26
DE60002855T2 (de) 2004-05-06
PT1173439E (pt) 2003-10-31
ATE240956T1 (de) 2003-06-15
EP1173439B1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
DK1173439T3 (da) Halogenalkoxy-imidazonaphthyridiner
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE527250T1 (de) 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
TR200002617T2 (tr) Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
DE60121345D1 (de) Alkylierte imidazopyridinderivate
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
ES2249309T3 (es) Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
ATE389655T1 (de) Pyrimidinderivate
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
ATE259813T1 (de) Triazolopyrimidinderivate
DE60315288D1 (de) Cyanoguanidin prodrugs
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ATE269313T1 (de) Tryptase-inhibitoren
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.